|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 38/12 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 38/12 | (2013.01) |
| (11) | Number of the document | 3528786 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17794677.9 |
| Date of filing the European patent application | 2017-10-17 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/076519 |
| Date | 2017-10-17 |
| (87) | Number | WO 2018/073269 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662411024 P | 2016-10-21 | US |
| (72) |
GJONI, Tina , HR
STRAZIC, Dubravka , HR
|
| (73) |
Xellia Pharmaceuticals ApS ,
Dalslandsgade 11, 2300 Copenhagen S,
DK
|
| (54) | LIQUID FORMULATIONS OF DAPTOMYCIN |
| LIQUID FORMULATIONS OF DAPTOMYCIN |